Everyday Health on MSNOpinion
Amifampridine for LEMS: How this first-line therapy works
Learn how amifampridine treats Lambert-Eaton myasthenic syndrome (LEMS), including its mechanism, dosing, benefits, side ...
Treatment for chronic inflammatory demyelinating polyneuropathy (CIDP) includes IV infusion at a medical clinic, but now you can get a similar treatment through an injection or infusion at home.
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced an agreement with the ADAP Crisis Task Force (ACTF) to help state AIDS Drug Assistance Programs (ADAPs) provide ...
Everyday Health on MSN
How pain is managed in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
Learn how pain is managed in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), including medications, therapies, procedures, and lifestyle strategies.
Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy Paris, June 10, 2026. Sanofi today announced that the riliprubart MOBILIZE phase ...
Semaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1) approved under two different U.S. Food and Drug ...
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare and severe immune-mediated disease that affects sensory ...
A.I.-generated images are the public face of this election overhaul. Behind the scenes, campaigns are using the technology to ...
Doctors at the Government General Hospital in Ongole treated a patient with rare Guillain-Barré Syndrome almost free of cost, ...
How does your body produce millions of antibodies from one genome? New research reveals how two closely related proteins help ...
Hundreds of Ballito residents dug deep to raise almost R100k for Ellie-Rae Reece at Mozambik Ballito's Carnivore Carnival.
DGRO's 5 year threshold for inclusion vs. VIG's 10-year on dividend appreciation shows a small ROI advantage for DGRO but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results